Literature DB >> 7617868

Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence.

R H Hashemi1, W G Bradley, D Y Chen, J E Jordan, J A Queralt, A E Cheng, J N Henrie.   

Abstract

PURPOSE: To compare thin-section, sagittal, fast fluid-attenuated inversion-recovery (FLAIR) magnetic resonance (MR) imaging with conventional axial spin-echo (SE) imaging for early detection of multiple sclerosis (MS) in the brain.
MATERIALS AND METHODS: Conventional 5-mm axial proton-density- and T2-weighted SE images and sagittal 2-mm fast FLAIR images of the brain in five healthy volunteers and 25 patients with clinically suspected MS were evaluated and graded as normal or as showing possible or probable MS in a double-blind study.
RESULTS: Fast FLAIR was judged better than SE in 37% of cases, equal to SE in 63%, and never worse than SE. In 43% of patients considered to have normal SE images, fast FLAIR images showed abnormalities consistent with MS. A subependymal striated appearance observed in several cases is believed to represent early inflammation and/or demyelination around subependymal veins in MS.
CONCLUSION: Sagittal thin-section fast FLAIR is superior to conventional axial proton-density- and T2-weighted SE pulse sequences for detection of MS plaques in the brain.

Entities:  

Mesh:

Year:  1995        PMID: 7617868     DOI: 10.1148/radiology.196.2.7617868

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

Review 1.  [Magnetic resonance imaging. Sequence acronyms and other abbreviations in MR imaging].

Authors:  W R Nitz
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

Review 2.  MR imaging of midbrain pathologies.

Authors:  E Hattingen; S Blasel; M Nichtweiss; F E Zanella; S Weidauer
Journal:  Clin Neuroradiol       Date:  2010-06-09       Impact factor: 3.649

3.  The ependymal "Dot-Dash" sign: an MR imaging finding of early multiple sclerosis.

Authors:  Christopher J Lisanti; Patrick Asbach; William G Bradley
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla.

Authors:  Rainald Bachmann; Ralf Reilmann; Wolfram Schwindt; Harald Kugel; Walter Heindel; Stefan Krämer
Journal:  Eur Radiol       Date:  2005-12-20       Impact factor: 5.315

5.  3D fluid-attenuated inversion recovery imaging: reduced CSF artifacts and enhanced sensitivity and specificity for subarachnoid hemorrhage.

Authors:  N Lummel; V Schoepf; M Burke; H Brueckmann; J Linn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

Review 6.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

7.  Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR.

Authors:  M Filippi; T A Yousry; H Alkadhi; M Stehling; M A Horsfield; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

8.  Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.

Authors:  A Lecler; I El Sanharawi; J El Methni; O Gout; P Koskas; J Savatovsky
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

9.  Hyperintense signal abnormality in subarachnoid spaces and basal cisterns on MR images of children anesthetized with propofol: new fluid-attenuated inversion recovery finding.

Authors:  C G Filippi; A M Ulug; D Lin; L A Heier; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

10.  Optimizing 3D FLAIR to detect MS lesions: pushing past factory settings for precise results.

Authors:  Augustin Lecler; C Bouzad; R Deschamps; F Maizeroi; J C Sadik; A Gueguen; O Gout; H Picard; J Savatovsky
Journal:  J Neurol       Date:  2019-08-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.